29
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Effect of Different Substituted Position of Phenylcarbamoyl‐β‐CD on the Enantioseparation of Drugs by Capillary Electrophoresis

, , &
Pages 293-306 | Received 01 Mar 2003, Accepted 01 Sep 2003, Published online: 16 Aug 2010
 

ABSTRACT

A number of acidic and basic chiral drugs such as β‐agonists, β‐antagonists, and phenylethylamines were separated by capillary electrophoresis with mono‐3‐O‐phenylcarbamoyl‐β‐CD and mono‐6‐O‐phenylcarbamoyl‐β‐CD. The effects of the CD type and concentration and the pH of the background electrolyte on the resolution of the drugs had been studied. The substituted position has a significant effect on the separation of chiral drugs and is therefore an important factor in the optimization of chiral resolution. Accordingly, a proper description of derived cyclodextrins should include substituted position.

Notes

Note: Separating conditions: capillary, 75 µm i.d. × 365 µm o.d. with 45 cm total length and 36 cm effective length; background electrolyte, 100 mmol L−1 NaH2PO4 buffer at pH 7.0; λ = 214 nm; 25°C. Applied voltage, 9 kV; injection: 9 kV/10 s.

Note: Separating conditions: capillary, 75 µm i.d. × 365 µm o.d. with 45 cm total length and 36 cm effective length; background electrolyte, 40 mmol L−1 borate buffer at pH 9.18; λ = 214 nm; 25°C. Applied voltage, 9 kV; injection: 9 kV/10 s.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.